| On the origins of three-dimensionality in drug-like molecules J Meyers, M Carter, NY Mok, N Brown Future Medicinal Chemistry 8 (14), 1753-1767, 2016 | 129 | 2016 |
| 8-Substituted Pyrido [3, 4-d] pyrimidin-4 (3 H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors V Bavetsias, RM Lanigan, GF Ruda, B Atrash, MG McLaughlin, A Tumber, ... Journal of medicinal chemistry 59 (4), 1388-1409, 2016 | 104 | 2016 |
| Mining the ChEMBL database: an efficient chemoinformatics workflow for assembling an ion channel-focused screening library NY Mok, R Brenk Journal of chemical information and modeling 51 (10), 2449-2454, 2011 | 59 | 2011 |
| A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase Inhibitors JR Harrison, S Brand, V Smith, DA Robinson, S Thompson, A Smith, ... Journal of medicinal chemistry 61 (18), 8374-8389, 2018 | 51 | 2018 |
| Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening NY Mok, J Chadwick, KAB Kellett, NM Hooper, AP Johnson, ... Bioorganic & medicinal chemistry letters 19 (23), 6770-6774, 2009 | 43 | 2009 |
| Locating sweet spots for screening hits and evaluating pan-assay interference filters from the performance analysis of two lead-like libraries NY Mok, S Maxe, R Brenk Journal of chemical information and modeling 53 (3), 534-544, 2013 | 28 | 2013 |
| Discovery of biphenylacetamide-derived inhibitors of BACE1 using de novo structure-based molecular design NY Mok, J Chadwick, KAB Kellett, E Casas-Arce, NM Hooper, ... Journal of medicinal chemistry 56 (5), 1843-1852, 2013 | 27 | 2013 |
| Binding to an unusual inactive kinase conformation by highly selective inhibitors of inositol-requiring enzyme 1α kinase-endoribonuclease G Colombano, JJ Caldwell, TP Matthews, C Bhatia, A Joshi, T McHardy, ... Journal of medicinal chemistry 62 (5), 2447-2465, 2019 | 26 | 2019 |
| Increasing the coverage of medicinal chemistry-relevant space in commercial fragments screening NY Mok, R Brenk, N Brown Journal of chemical information and modeling 54 (1), 79, 2014 | 24 | 2014 |
| Privileged Structures and Polypharmacology within and between Protein Families J Meyers, NEA Chessum, S Ali, NY Mok, B Wilding, AE Pasqua, ... ACS medicinal chemistry letters 9 (12), 1199-1204, 2018 | 21 | 2018 |
| HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies AE Pasqua, SY Sharp, NEA Chessum, A Hayes, L Pellegrino, MJ Tucker, ... Journal of Medicinal Chemistry 66 (8), 5907-5936, 2023 | 17 | 2023 |
| C8-substituted pyrido [3, 4-d] pyrimidin-4 (3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 … YV Le Bihan, RM Lanigan, B Atrash, MG McLaughlin, S Velupillai, ... European journal of medicinal chemistry 177, 316-337, 2019 | 17 | 2019 |
| Applications of Systematic Molecular Scaffold Enumeration to Enrich Structure–Activity Relationship Information NY Mok, N Brown J. Chem. Inf. Model 57 (1), 27-35, 2017 | 13 | 2017 |
| Optimisation of the Anti‐Trypanosoma brucei Activity of the Opioid Agonist U50488 VC Smith, LAT Cleghorn, A Woodland, D Spinks, I Hallyburton, IT Collie, ... ChemMedChem 6 (10), 1832-1840, 2011 | 10 | 2011 |
| Pyrido[3,4-d]pyrimidin-4(3H)-one metabolism mediated by aldehyde oxidase is blocked by C2-substitution A Hayes, NY Mok, M Liu, C Thai, AT Henley, B Atrash, RM Lanigan, ... Xenobiotica 47 (9), 771-777, 2017 | 7 | 2017 |
| Metabolism of the dual FLT-3/Aurora kinase inhibitor CCT241736 in preclinical and human in vitro models: Implication for the choice of toxicology species FL Wood, S Shepherd, A Hayes, M Liu, K Grira, Y Mok, B Atrash, A Faisal, ... European Journal of Pharmaceutical Sciences 139, 104899, 2019 | 6 | 2019 |
| Exploiting Vector Pattern Diversity of Molecular Scaffolds for Cheminformatics Tasks in Drug Discovery D Dolciami, RM Ziolek, DW Davies, M Carter, NY Mok, R Sherhod Journal of Chemical Information and Modeling 64 (6), 1966-1974, 2024 | 4 | 2024 |
| Quinoline derivatives as inhibitors of heat shock factor 1 pathway activity K Jones, M Cheeseman, N Chessum, E Pasqua, L Evans, M Tucker, ... WO Patent WO2016/156,872, 2018 | 4 | 2018 |
| Protein Structure-informed Molecular Fragment Replacement with InteractionDB G Mattedi, M Gatti Iou, A Potterton, Y Mok Proceedings of the Ninth Joint Sheffield Conference on Chemoinformatics …, 2023 | | 2023 |
| New benzamide compounds as c-ABL inhibitors and methods for their preparation and use
R Paul, M Rackham, Y Mok, M Vass, J Meyers, A Cronin, A Mandal WO Patent WO/2020/260,871, 2020 | | 2020 |
Ruth BrenkUniversity of BergenZweryfikowany adres z uib.no